Skip to main content

Table 1 Comparison of the four metabolic groups according to data from the 1st visit

From: Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults

 

Healthy on both visits

Healthy on visit 1; unhealthy on visit 2

p-value

Metabolically unhealthy on both visits

p-value (all three groups)

Total population

N (%)

1311 (16.9)

985 (12.7)

 

5463 (70.4)

 

7759 (100)

Age, mean (SD)

39.3 (9.7)

42.0 (9.9)

< 0.001

48.0 (10.3)

< 0.001

45.7 (10.7)

Gender (males) N (%)

740 (56.4)

644 (65.4)

< 0.001

3850 (70.5)

< 0.001

5234 (67.5)

Current Smoking N (%)

169 (14.2)

119 (13.3)

0.584

573 (11.8)

0.048

861 (12.4)

Previous smoker N (%)

197 (15.0)

170 (17.3)

0.136

1230 (22.5)

< 0.001

1597 (20.6)

Diastolic, mmHg

71.4 (5.8)

72.5 (5.6)

< 0.001

78.6 (8.2)

< 0.001

76.6 (8.2)

Systolic, mmHg

111.4 (8.9)

113.1 (8.8)

< 0.001

125.5 (15.0)

< 0.001

121.6 (14.8)

BMI, kg/\({m}^{2}\)

23.5 [21.7–25.2]

22.8 [24.4–26.2]

< 0.001

26.9 [24.6–29.7]

< 0.001

26.3 [23.6–28.5]

Waist circumference, cm

82.0 [75.0–89.0]

85.0 [79.0–92.0]

< 0.001

94.0 [87.0–102.0]

0.000

91.0 [82.0–99.0]

Average of weekly hours of physical exercise

2.0 [0.0–3.3]

2.0 [0.0–3.7]

0.659

1.7 [0.0–3.0]

0.008

2.0 [0.0–3.0]

FPG, mg/dL

86.0 [81.0–90.0]

88.0 [83.0–92.0]

< 0.001

92.0 [86.0–100.0]

< 0.001

90.0 [85.0–97.0]

HbA1C (%)

5.1 [4.9–5.3]

5.2 [5.0–5.4]

< 0.001

5.4 [5.1–5.7]

< 0.001

5.3 [5.1–5.6]

Triglycerides mg/dL

74.0 [57.0–97.3]

80.0 [61.0–107.0]

< 0.001

116.0 [80.0–163.0]

< 0.001

101.0 [72.0–143.0]

HDL mg/dL

61.6 (13.9)

58.5 (13.5)

< 0.001

52.7 (13.2)

< 0.001

54.9 (13.8)

Hs-CRP, mg/L

0.9 [0.5–1.8]

1.1 [0.6–2.1]

0.014

1.6 [0.8–3.5]

< 0.001

1.4 [0.7–3.0]

High Hs-CRP > 3.0 md/dL, N (%)

186 (14.4)

144 (15.7)

0.404

1597 (29.5)

 < 0.001

1927 (25.3)

Creatinine mg/dL

1.0 (0.1)

1.1 (0.1)

< 0.001

1.1 (0.2)

< 0.001

1.1 (0.2)

High creatinine (males > 1.3 females > 1.1) N (%)

73 (5.9)

68 (7.6)

0.110

513 (9.6)

< 0.001

654 (8.8)

Neutrophils, %

58.3 (7.8)

58.4 (7.7)

0.782

59.5 (7.6)

< 0.001

59.1 (7.6)

Lymphocytes, %

31.0 (6.8)

30.8 (6.9)

0.581

29.8 (6.8)

< 0.001

30.1 (6.8)

Monocytes, %

7.4 [6.3–8.7]

7.5 [6.4–8.7]

0.793

7.4 [6.3–8.6]

0.644

7.4 [6.3–8.6]

Eosinophils, %

2.2 [1.4–3.3]

2.2 [1.4–3.6]

0.284

2.3 [1.5–3.5]

0.384

2.3 [1.4–3.5]

Basophils, %

0.5 [0.4–0.6]

0.5 [0.4–0.6]

0.841

0.5 [0.4–0.6]

0.147

0.5 [0.4–0.6]

fibrinogen, g/L

277.2 (56.5)

284.4 (56.4)

0.004

299.6 (60.4)

< 0.001

293.9 (60.0)

Albumin, g/L

45.1 (2.5)

45.1 (2.4)

0.962

45.1 (2.3)

0.842

45.1 (2.4)

BUN, mg/dL

13.0 [11.0–16.0]

14.0 [12.0–16.0]

< 0.001

14.0 [12.0–17.0]

< 0.001

14.0 [12.0–17.0]

PLT, \({x10}^{3}\)/µL

242.1 (54.7)

246.1 (52.5)

0.089

250.8 (60.2)

< 0.001

248.8 (58.5)

RBC, \(x{10}^{6}\)/µL

4.7 (0.5)

4.7 (0.4)

0.001

4.8 (0.4)

< 0.001

4.8 (0.4)

WBC, \({x10}^{3}\)/µL

6.3 (1.4)

6.5 (1.4)

0.001

6.8 (1.7)

< 0.001

6.7 (1.6)

Hemoglobin, g/dL

14.1 (1.3)

14.2 (1.3)

0.010

14.4 (1.3)

< 0.001

14.3 (1.3)

Bilirubin, mg/dL

0.8 (0.4)

0.8 (0.4)

0.482

0.8 (0.3)

< 0.001

0.8 (0.4)

AST U/L

21.0 [18.0–25.0]

22.0 [19.0–25.0]

0.720

23.0 [20.0–26.0]

< 0.001

22.0 [19.0–26.0]

ALT U/L

21.6 (10.8)

22.4 (10.2)

0.067

27.1 (13.8)

< 0.001

25.6 (13.2)

Uric acid mg/dL

5.0 (1.2)

5.2 (1.2)

< 0.001

5.7 (1.3)

< 0.001

5.5 (1.3)

Globulin, g/L

28.2 (3.2)

28.4 (3.2)

0.105

28.6 (3.3)

< 0.001

28.5 (3.3)

ALP U/L

52.0 [43.0–64.0]

54.0 [46.0–66.0]

< 0.001

59.0 [49.0–71.0]

< 0.001

57.0 [47.0–69.0]

LDH U/L

297.0 (49.1)

302.3 (49.9)

0.014

314.5 (52.9)

< 0.001

310.1 (52.4)

GGT U/L

11.0 [7.0–16.0]

13.0 [9.0–18.0]

0.009

16.0 [11.0–24.0]

< 0.001

15.0 [10.0–22.0]

Phosphorus, mg/dL

3.4 (0.5)

3.4 (0.4)

0.088

3.3 (0.5)

< 0.001

3.3 (0.5)

Protein total, g/L

73.3 (4.0)

73.5 (4.0)

0.204

73.6 (3.9)

0.021

73.6 (4.0)

Total cholesterol mg/dL

186.5 (32.5)

190.9 (33.5)

0.002

198.2 (36.6)

< 0.001

195.3 (35.9)

LDL mg/dL

109.4 (28.7)

115.3 (29.6)

< 0.001

119.2 (30.9)

< 0.001

117.1 (30.6)

High total cholesterol > 200 N (%)

394 (31.5)

334 (37.3)

0.005

2457 (46.2)

< 0.001

3185 (42.7)

High LDL > 130 N (%)

288 (23.1)

274 (30.6)

< 0.001

1850 (35.0)

< 0.001

2412 (32.5)

Chloride, mmol/L

104.0 (2.3)

104.0 (2.3)

0.981

103.8 (2.5)

0.004

103.9 (2.4)

Potassium, mmol/L

4.3 (0.4)

4.3 (0.4)

0.045

4.4 (0.4)

 < 0.001

4.4 (0.4)

Calcium, mg/dL

9.2 (0.4)

9.3 (0.4)

0.756

9.3 (0.4)

0.569

9.3 (0.4)

Sodium, mmol/L

141.1 (2.5)

141.2 (2.7)

0.138

141.3 (2.6)

0.030

141.3 (2.6)

FVC

103.0 [95.0–112.0]

102.0 [94.0–111.0]

0.592

100.0 [92.0–109.0]

< 0.001

101.0 [93.0–110.0]

FEV

100.9 (12.8)

100.6 (12.6)

0.564

98.5 (14.8)

< 0.001

99.2 (14.2)

FEV/FVC

102.0 [97.0–106.0]

102.0 [97.0–106.0]

0.578

102.0 [97.0–107.0]

0.778

102.0 [97.0–107.0]

Microalbumin urine

3.7 [0.7–8.0]

3.3 [0.9–8.0]

0.452

4.5 [1.1–10.3]

< 0.001

4.1 [1.0–9.6]

PHQ

10.0 [9.0–12.0]

10.0 [9.0–12.0]

0.609

10.0 [9.0–12.0]

0.106

10.0 [9.0–12.0]

  1. Values are presented as mean (SD), or median [IQR] for irregular distributed parameters. Bold values are significant.